BioAffinity Technologies Q1 EPS $(0.21) Down From $(0.18) YoY, Sales $2.41M Up From $921.00 YoY
BioAffinity Technologies Q1 EPS $(0.21) Down From $(0.18) YoY, Sales $2.41M Up From $921.00 YoY
BioAffinity Technologies第一季度每股收益美元（0.21美元）低於同比0.18美元，銷售額爲241萬美元，高於同比921.00美元
bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.21) per share. This is a 16.67 percent decrease over losses of $(0.18) per share from the same period last year. The company reported $2.41 million in sales this quarter. This is a 261.18K percent increase over sales of $921.00 the same period last year.
BioAffinity Technologies（納斯達克股票代碼：BIAF）報告稱，季度每股虧損爲0.21美元。這比去年同期每股虧損0.18美元（0.18美元）下降了16.67％。該公司報告本季度銷售額爲241萬美元。這比去年同期的921.00美元的銷售額增長了261.18萬美元百分點。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。